Latest news, press releases, and SEC filings for Immix Biopharma Inc (IMMX) https://caymanjournal.com/stock/IMMX en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:27:24 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 Here's a clear breakdown of Immix Biopharma's (IMMX) proxy statement, focusing on what matters most to shareholders. # 🧾 What This Document Is This is a **Definitive Proxy Statement (DEF 14A)**. It's like an "invitation and instruction manual" for Immix Biopharma's 2026 Annual Meeting of Stockhold https://caymanjournal.com/stock/IMMX/sec-filing/0001493152-26-015320 https://caymanjournal.com/stock/IMMX/sec-filing/0001493152-26-015320 Mon, 06 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is Immix Biopharma's **Annual Report (ARS)** for the fiscal year ended December 31, 2023. Think of it as the company's yearly "check-up" report to the SEC and its investors. It's a comprehensive look at their business, financial health, and progress on their goals ov https://caymanjournal.com/stock/IMMX/sec-filing/0001493152-26-015324 https://caymanjournal.com/stock/IMMX/sec-filing/0001493152-26-015324 Mon, 06 Apr 2026 00:00:00 GMT SEC Filing